Learning while Doing

Trials extracted from the podcast by Rob Mac Sweeney

• 2021REMAP-CAPICU & Critical CareIn 895 critically ill adults with Covid-19 receiving organ support, tocilizumab or sarilumab increased organ support-free days compared with usual care.
• 2022OPTIMISE-C19Infection & AntimicrobialsIn 1935 outpatients with mild-to-moderate COVID-19, bamlanivimab-etesevimab yielded hospital-free days to day 28 similar to casirivimab-imdevimab.